Publications

Found 125 results
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
5
Stoyan T, Thrower D, Clegg D.  2009.  A 5-year BS/MA program in Pharmacology and Biotechnology at UC Santa Barbara. The FASEB Journal. 23
A
Clegg DO, Mullick LH, Wingerd KL, Lin H, Atienza JW, Bradshaw AD, Gervin DB, Cann GM.  2000.  Adhesive events in retinal development and function: the role of integrin receptors. Vertebrate Eye Development. :141–156.
Siegel KR, Clevenger TN, Clegg DO, Proctor DA, Proctor CS.  2017.  Adipose Stem Cells Incorporated in Fibrin Clot Modulate Expression of Growth Factors. Arthroscopy.
Wingerd KL, Goodman N, Leu ST, Smail M, Rohan SX, Clegg DO.  2001.  Alpha4 integrins and vascular cell adhesion molecule-1 play a role in sympathetic innervation of the heart. Molecular Biology of the Cell. 12:319A–320A.
Wingerd KL, Goodman NL, Tresser JW, Smail MM, Leu ST, Rohan SJ, Pring JL, Jackson DY, Clegg DO.  2002.  Alpha4 integrins and vascular cell adhesion molecule-1 play a role in sympathetic innervation of the heart. The Journal of Neuroscience. 22(24):10772-80.
Kil SH, Krull CE, Cann G, Clegg D, Bronner-Fraser M.  1998.  The alpha4 subunit of integrin is important for neural crest cell migration. Developmental Biology. 202(1):29-42.
Clegg DO, Helder JC, Hann BC, Hall DE, Reichardt LF.  1988.  Amino acid sequence and distribution of mRNA encoding a major skeletal muscle laminin binding protein: an extracellular matrix-associated protein with an unusual COOH-terminal polyaspartate domain. The Journal of Cell Biology. 107(2):699-705.
Hansma HG, Clegg DO, Kokkoli E, Oroudjev E, Tirrell M.  2002.  Analysis of matrix dynamics by atomic force microscopy. Methods in Cell Biology. 69:163–193.
Lin H, Clegg DO.  1996.  Arg-Gly-Asp containing peptide inhibits ROS phagocytosis by cultured human RPE. Investigative Ophtahlmology & Visual Science. 37:1750–1750.
Lin T-C, Seiler MJ, Zhu D, Falabella P, Hinton DR, Clegg DO, Humayun MS, Thomas BB.  2017.  Assessment of Safety and Functional Efficacy of Stem Cell-Based Therapeutic Approaches Using Retinal Degenerative Animal Models. Stem Cells Int. 2017:9428176.
B
Ahuja A, Clegg D, Grubbs R, Hinton D, Humayun M, Tai YC.  2011.  Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same.
Humayun M, Ahuja A, Tai Y-C, Hinton D, Grubbs R, Clegg D, JOHNSON LVallance, Hikita ST, .  2011.  Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same.
Piunova V, Patel P, Lee C, Tsie M, Grubbs RH, Clegg DO.  2012.  Biodegradable polymer scaffolds for stem-cell based treatment of age-related macular degeneration.
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin C-M, Mitra D, Zhu D, Thomas BB et al..  2018.  A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.. Science Translational Medicine. 10(435)
Stevanovic M, Mitra D, Clegg DO, Humayun MS.  2019.  Biomaterials and Scaffolds for Cell Replacement Therapy. Cell-Based Therapy for Retinal Degenerative Disease. :109-140.
C
Leach LL, Buchholz DE, Nadar VP, Lowenstein SE, Clegg DO.  2015.  Canonical/β-catenin Wnt pathway activation improves retinal pigmented epithelium derivation from human embryonic stem cells. Investigative Ophthalmology & Visual Science. 56(2):1002-13.
Clevenger TN, Luna G, Boctor D, Fisher SK, Clegg DO.  2016.  Cell-mediated remodeling of biomimetic encapsulating hydrogels triggered by adipogenic differentiation of adipose stem cells. J Tissue Eng. 7:2041731416670482.
Forest DL, Johnson LV, Clegg DO.  2015.  Cellular models and therapies for age-related macular degeneration. Disease Models & Mechanisms. 8(5):421-7.
Clegg DO.  1993.  Characterization of a beta-nerve growth factor expression vector for mammalian cells. Gene. 130(2):291-6.
Leach LL, Clegg DO.  2015.  Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease. Stem Cells. 33(8):2363-73.
D
Clegg DO, Rowland T.  2010.  Daniel E. Koshland Jr.. Proceedings of the American Philosophical Society. 154:477.
Pennington BO, Clegg DO, Melkoumian ZK, Hikita ST.  2015.  Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate. Stem Cells Translational Medicine. 4(2):165-77.
Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Johnson LV, Clegg DO.  2009.  Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells. 27(10):2427-34.
Clegg DO, Hikita ST, Hu Q, Buchholz DE, Rowland TJ, Conti L, Pennington B, Croze R, Leach L, Tsie M et al..  2013.  Derivation of retinal pigmented epithelial cells from pluripotent stem cells. The Stem Cell Handbook.
Raichman M, Panzeri MC, Clementi E, Papazafiri P, Eckley M, Clegg DO, Villa A, Meldolesi J.  1995.  Differential localization and functional role of calsequestrin in growing and differentiated myoblasts. The Journal of Cell Biology. 128(3):341-54.

Pages